Epstein-Barr Virus-induced Hemophagocytic Lymphohistiocytosis
| Autor: | Goudarzipour, K., Kajiyazdi, M., Mahdaviyani, A. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
endocrine system
fungi Case Report musculoskeletal system lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 Systemic Inflammatory Response Syndrome Etanercept X-Linked Lymphohistiocytosis Disease X-Linked lymphoproliferative disease hemic and lymphatic diseases Hemophagocytic Lymphohistiocytosis Infectious Mononucleosis Epstein-Barr Virus Epstein - Barr virus hormones hormone substitutes and hormone antagonists |
| Zdroj: | International Journal of Hematology-Oncology and Stem Cell Research, Vol 7, Iss 1, Pp 39-42 (2013) International Journal of Hematology-Oncology and Stem Cell Research, Vol 7, Iss 1 (2013) International Journal of Hematology-Oncology and Stem Cell Research |
| ISSN: | 2008-2207 2008-3009 |
| Popis: | Hemophagocytic lymphohistiocytosis (HLH) is one of the complications of Epstein-Barr virus (EBV) infection. Although the patients who have developed HLH following EBV have normal immune system, there are a few patients with EBV-induced immune deficiency who develop HLH as well. Here, we describe the case of a 10-year-old girl with neurological complications caused by EBV-induced HLH. The patient received rituximab, leading to weakening inflammation associated with EBV infection and suppression of disease through quick treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|